Aker BioMarine will release the fourth quarter 2025 results on Thursday 12
February 2026 at 07:00 CET.
At 09:00 CET on the same day, the management will host a webcast to present the
results. Following a presentation, there will be a Q&A session where written
questions can be submitted to ir@akerbiomarine.com.
The webcasted presentation will be in English. To join, please use the link that
will be available at www.akerbiomarine.com/investor.
A replay of the presentation and Q&A session will be made available soon after
the presentation at the same web page.
For further information, please contact
Christopher Robin Vinter, VP Strategic Finance & IR
Mobile: +47 911 60 820
Email: christopher.vinter@akerbiomarine.com
About Aker BioMarine
Aker BioMarine is a leading human health and nutrition innovator that develops
krill-derived products for consumer health and nutrition. Krill is a natural,
powerful, and health-promoting source of nutrients from the pristine waters of
Antarctica, and Aker BioMarine has a unique position in its industry. The
ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+,
as well as the consumer brand, Kori Krill. The innovative approach also extends
into the spin-offs AION (reduce and recycle plastic waste across industries) and
Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock
Exchange (AKBM). More information is available at www.akerbiomarine.com.